UDP-glucuronosyltransferase (UGT) 1A1 mainly contributes to the glucuronidation of trovafloxacin

Drug Metabolism and Pharmacokinetics
Ryoichi FujiwaraTomoo Itoh

Abstract

Identification of drug-metabolizing enzyme(s) responsible for the metabolism of drugs is an important step to understand not only interindividual variability in pharmacokinetics but also molecular mechanisms of metabolite-related toxicity. While it was reported that the major metabolic pathway of trovafloxacin, which is an antibiotic, was glucuronidation, the UDP-glucuronosyltransferase (UGT) isoform(s) responsible for the trovafloxacin glucuronidation has not been identified yet. In the present study, among the functional human UGT members, UGT1A1, UGT1A3, and UGT1A9 exhibited higher trovafloxacin acyl-glucuronidation activities. While other UGT members such as UGT1A8, UGT2B7, and UGT2B15 showed glucuronidation activity toward trovafloxacin, the metabolic velocity was extremely low. In human liver microsomes, trovafloxacin acyl-glucuronidation followed the Hill equation with S50 value of 95 μM, Vmax value of 243 pmol/min per mg, and a Hill coefficient of 2.0, while the UGT1A1-expressing system displayed Michaelis-Menten kinetics with a substrate inhibition, with Km value of 759 μM and Vmax value of 1160 pmol/min per mg. In human liver microsomes prepared from poor metabolizers (UGT1A1*28/*28), significantly reduced trovafloxac...Continue Reading

References

May 1, 1993·Proceedings of the National Academy of Sciences of the United States of America·A DingL Z Benet
Feb 15, 2000·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·M I LucenaR Alcantára
Jun 3, 2000·Annual Review of Pharmacology and Toxicology·R H Tukey, C P Strassburg
Nov 16, 2002·Drug Metabolism and Disposition : the Biological Fate of Chemicals·Miki NakajimaTsuyoshi Yokoi
Aug 12, 2004·Drug Metabolism and Disposition : the Biological Fate of Chemicals·J Andrew WilliamsSimon E Ball
Dec 25, 2004·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Michael J LiguoriJeffrey F Waring
Sep 6, 2005·Pharmacogenetics and Genomics·Peter I MackenzieDaniel W Nebert
Feb 13, 2007·Drug Metabolism and Disposition : the Biological Fate of Chemicals·Ryoichi FujiwaraTsuyoshi Yokoi
Jul 11, 2007·Drug Metabolism and Disposition : the Biological Fate of Chemicals·Ryoichi FujiwaraTsuyoshi Yokoi
May 16, 2008·Drug Metabolism and Disposition : the Biological Fate of Chemicals·Akiko NakamuraTsuyoshi Yokoi
Nov 5, 2008·The Journal of Biological Chemistry·Peter I MackenzieRobyn Meech
May 15, 2009·Drug Metabolism and Disposition : the Biological Fate of Chemicals·Takeshi IzukawaTsuyoshi Yokoi
Oct 10, 2009·Drug Metabolism Reviews·Robyn Meech, Peter I Mackenzie
Oct 13, 2009·Drug Metabolism Reviews·Yuji IshiiHideyuki Yamada
Nov 23, 2010·Molecular Pharmacology·Peter I MacKenzieRobyn Meech
Apr 26, 2014·Drug Metabolism and Disposition : the Biological Fate of Chemicals·Yuki KutsunoRyoichi Fujiwara

❮ Previous
Next ❯

Citations

Oct 8, 2016·Toxicology Letters·Ryo MitsugiRyoichi Fujiwara
Apr 20, 2017·Molecules : a Journal of Synthetic Chemistry and Natural Product Chemistry·Ming HongYibin Feng

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cancer Metabolism

In order for cancer cells to maintain rapid, uncontrolled cell proliferation, they must acquire a source of energy. Cancer cells acquire metabolic energy from their surrounding environment and utilize the host cell nutrients to do so. Here is the latest research on cancer metabolism.